ArticleVaccines2023

Remdesivir Alone or in Combination with Monoclonal Antibodies as an Early Treatment to Prevent Severe COVID-19 in Patients with Mild/Moderate Disease at High Risk of Progression: A Single Centre, Real-Life Study.

Riccardo Scotto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.